Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma
Authors:
- 24 April 2020
- journal article
- letter
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 44 (9) , 1290-1292
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 6 references indexed in Scilit:
- Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant MesotheliomaAmerican Journal of Surgical Pathology, 2019
- Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant MesotheliomaJournal of Clinical Oncology, 2018
- Correction: Author Correction: Integrated genomic analyses of de novo pathways underlying atypical meningiomasNature Communications, 2018
- Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancersJournal of Medical Genetics, 2011
- Germline BAP1 mutations predispose to malignant mesotheliomaNature Genetics, 2011
- DNA glycosylase encoded by MUTYH functions as a molecular switch for programmed cell death under oxidative stress to suppress tumorigenesisCancer Science, 2011